TRIP13 overexpression in hepatocellular carcinoma: implications for poor prognosis and immune cell infiltration

PURPOSE: The overexpression of TRIP13 has been observed in many types of cancer and has been identified as an oncogene. However, its role in hepatocellular carcinoma (HCC) has not been extensively studied. This study aimed to investigate the expression of TRIP13 in HCC and its impact on immune cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Jiapeng, Wu, Hongfen, Shi, Yun, Li, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516817/
https://www.ncbi.nlm.nih.gov/pubmed/37740123
http://dx.doi.org/10.1007/s12672-023-00792-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516817/
https://www.ncbi.nlm.nih.gov/pubmed/37740123
http://dx.doi.org/10.1007/s12672-023-00792-2

Ejemplares similares